Gene Query: NOL7

Dataset Description Geneva Score
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 59.42
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 45.79
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (3' RNA) 44.92
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 42.52
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 33.81
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 33.19
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 26.93
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 26.93
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 25.98
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 20.85
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation 19.63
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 19.57
The effects of chemokines CCL2/7 on MDA-MB-231-FOXC1 cells 19.28
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 18.48
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 18.48
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 18.42
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 18.42
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 17.88
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 16.97
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 16.08
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 16.08
WNK1 kinase and the termination factor PCF11 connect nuclear mRNA export with transcription 15.88
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 14.81
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 14.51
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 14.42
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 14.35
Global analysis of enhancer targets: Mosaic-seq 14.33
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 14.22
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 13.89
BET-Bromodomain Inhibitors Engage The Host Immune System And Regulate Expression Of The Immune Checkpoint Ligand PD-L1 [3mRNA-seq] 13.89
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 13.7
Phosphatase inhibitor PPP1R11 modulates resistance of human T cells towards Treg-mediated suppression of TCR signaling 13.5
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 13.4
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 13.07
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 12.62
Trans-chromosomal regulation by a novel lincRNA required for adipogenesis that escapes X-chromosome inactivation 12.21
Heterozygous p53-R280T mutation promotes proliferation of NPC cells through activating PI3K/Akt signaling pathway 12.2
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 12.05
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 11.98
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 11.9
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 11.84
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 11.77
PolyA-sequencing in IMR-32 cells treated with THZ531 or DMSO 11.51
Transcriptomic analysis of human tonsillar TFH subsets 11.4
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 11.31
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 11.17
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 11.17
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 11.16
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 11.09
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 11.09
Next Generation Sequencing Facilitates Quantitative Analysis of ALDH+ E-BCSC, CD24-CD44+ M-BCSC and Bulk tumor cell Transcriptomes from MC1 and Vari068 PDX models of TNBC 11.08
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 11.04
Hijacking of stress response machinery by oncogenes in acute leukaemia 11.04
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 11.0
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 11.0
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 10.68
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 10.46
Transcriptional profiling of microglia; current state of the art and future perspectives 10.43
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 10.39
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 10.22
HEK293 Heat-shock experiment 10.22
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 10.21
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 10.21
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 10.1
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 10.04
KLF6-dependent transcription in renal cancer cells 10.0
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 9.99
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 9.98
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 9.93
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 9.85
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 9.76
A novel Menin-MLL inhibitor induces specific chromatin changes and eradicates disease in models of MLL-rearranged leukemia [RNA-Seq II] 9.61
Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion 9.55
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 9.48
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 9.46
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 9.38
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 9.34
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 9.3
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 9.24
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 9.24
Fbxo32 mediated gene expression program underlies EMT and metastasis 9.22
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 9.21
Single-nucleotide-resolution mapping of HBV promoters using CAGE 9.07
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 9.07
CROP-Seq in Primary Human T Cells 9.01
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 9.01
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 9.0
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 8.91
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 8.91
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 8.85
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 8.81
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 8.75
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 8.72
Seletive inhibition of CDK9 in DLBCL cell lines 8.67
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 8.63
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 8.6
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 8.56
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 8.54
METTL3 promotes translation in human cancer cells 8.51
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 8.49
Developmental stage specific chromosome architecture in human erythroid cells 8.49
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 8.44
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 8.39
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 8.39
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 8.37
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 8.29
Identification of transcription start sites for human A549 cell line using ReCappable-seq 8.27
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 8.26
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 8.24
XBP1s Activation Globally Remodels N-Glycan Structure Distribution Patterns 8.24
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 8.23
Cajal bodies are linked to genome conformation [RNA-Seq] 8.18
Cajal bodies are linked to genome conformation 8.18
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 8.18
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 8.09
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 7.97
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 7.97
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 7.89
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 7.83
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 7.82
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 7.8
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 7.8
Role of cervicovaginal microbiota in genital inflammation 7.8
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 7.78
MYCi975 regulates MYC target genes 7.73
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 7.68
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 7.68
Molecular Mechanisms of Endothelial Hyperpermeability 7.62
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 7.53
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 7.48
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 7.48
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 7.46
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 7.39
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 7.38
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 7.37
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 7.34
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 7.29
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 7.24
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 7.22
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 7.13
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 7.1
3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations 7.08
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 7.07
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 7.05
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 7.02
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 6.97
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 6.9
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 6.86
RNA-sequencing of formalin fixed human primary melanoma tissue 6.79
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 6.76
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 6.71
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 6.7
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 6.68
Trans-differentiation of human adult peripheral blood T cells into neurons 6.68
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 6.66
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 6.64
TFPa/HADHA is required for fatty acid beta-oxidation and cardiolipin re-modeling in human cardiomyocytes 6.63
Genes significantly down or Up-regulated upon RNF219 knockdown 6.56
Co-transcriptional loading of RNA export factors shapes the human transcriptome 6.56
RNAseq of HEK293 cells after Chtop knockdown 6.56
Transcriptome analysis of SKI knock-out in HL60 cells 6.52
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 6.52
RNA-seq of overgrown interscapular adipose tissue with biallelic MFN2 mutations 6.51
Transcriptome of activated human and mouse MAIT cells 6.49
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 6.48
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 6.48
The evolution of N6-methyladenosine in primates 6.48
RNA-seq of YB5 cells treated with Proscillaridin A 6.48
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 6.46
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 6.38
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 6.35
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 6.34
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 6.34
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 6.34
Spliceosomal disruption of the non-canonical BAF complex in cancer 6.33
Integrating single-cell transcriptomic data across different conditions, technologies, and species 6.3
Genome-wide maps in MCF-7 cells with six2 or CYP4Z1 3'UTR or CYP4Z2P 3'UTR overexpression or not 6.29
Identification of renal resident macrophages across species 6.27
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 6.27
IL-1β induces the rapid secretion of the antimicrobial protein IL-26 from Th17 cells 6.26
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 6.26
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 6.26
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 6.26
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 6.24
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 6.19
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 6.19
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 6.18
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 6.18
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 6.18
Landscape and variation of RNA secondary structure across the human transcriptome 6.17
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 6.14
Pharmacologic inhibition of STAT5 in AML 6.13
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 6.13
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 6.12
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 6.11
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 6.11
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 6.07
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 6.05
Expression alterations induced by restoration of AXIN1 expression in SNU449 hepatocellular carcinoma cells 5.99
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 5.97
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 5.96
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 5.96
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 5.95
RNA-seq analysis of uveal melanoma cells treated with FR900359 5.91
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 5.9
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 5.89
Differentially Expressed Genes upon Knockdown of ZRANB1 or EZH2 in LM2 Cells 5.89
Gene expression changes caused by KRAS in MCF-10A 5.84
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 5.83
Isolation and sequencing of AGO-bound RNAs reveals characteristics of stem-loop processing in vivo 5.81
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 5.81
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 5.78
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 5.77
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 5.76
RNA sequencing of primary human platelets and in vitro cell lines 5.75
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 5.74
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 5.74
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 5.74
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 5.73
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 5.73
Total RNA-seq in ALL-SIL upon TLX1 knockdown 5.72
TCR and inflammatory signals tune human MAIT cells to exert specific tissue repair and effector functions 5.7
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 5.68
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 5.67
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 5.67
CD73 knockdown effect in pancreatic cancer cell lines 5.65
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 5.64
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 5.64
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 5.61
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 5.61
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 5.6
Generating Patterned Kidney Organoids for Studying Development and Diseases 5.58
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 5.57
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 5.57
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 5.55
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 5.55
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 5.52
Ribosomal protein RPL26 is the principal target of UFMylation 5.51
RNA-seq of MDA-MB-231 cells with TET1 knockout 5.51
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 5.51
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 5.51
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 5.47
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 5.47
Comprehensive comparative analysis of 5’ end RNA sequencing methods 5.44
High-throughput sequencing of PROMPT-enriched samples. 5.42
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 5.4
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 5.37
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 5.35
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 5.34
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 5.34
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 5.3
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 5.29
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 5.29
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 5.24
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 5.21
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 5.21
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 5.21
Integrated epigenomic and transcriptomic profiling of terminal human erythropoiesis [TMCC2] 5.19
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 5.17
Lung Cancer Cell-Mediated Skeletal Muscle Mitochondrial Dysfunction is Mitigated by 1a,25-Dihydroxyvitamin D3 5.13
Analysis by Whole Transcriptome Sequencing of the Effects of LLC1 conditioned medium, LLC1 conditioned plus Calcitriol, non-conditioned medium, and non-conditioned medium plus Calcitriol on mRNA Expression in Primary Human Skeletal Muscle Cells 5.13
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 5.11
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 5.1
Identification of Sin3B regulated genes during quiescence 5.06
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 4.99
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 4.97
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 4.87
RNA m5C Methylation in breast cancer using MeRIP-Seq 4.83
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 4.82
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 4.8
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 4.79
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 4.79
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 4.78
PolyA-sequencing in Kelly and Kelly E9R neuroblastoma cells treated with THZ531 or DMSO 4.75
Ribosome profiling upon inhibition of eIF4A 4.7
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 4.69
Enhancement of Arterial Specification in Human Pluripotent Stem Cell Cultures Promotes Definitive Hematoendothelial Program with Broad Myelolymphoid Potential 4.68
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 4.66
The Genomic Landscape of Atypical Fibroxanthoma 4.64
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 4.59
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 4.56
Germline NLRP1 mutations cause skin inflammatory and cancer susceptibility syndromes via inflammasome activation 4.54
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 4.54
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 4.54
Discovery and verification of liver cancer marker genes and variable scission based on second-generation sequencing data analysis 4.54
Total RNA-seq in ALL-SIL upon JQ1 inhibition 4.51
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 4.43
The effect of Abl kinases on non-small cell carcinoma global transcriptome 4.4
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 4.38
Global response to chemotherapy-induced apoptosis 4.37
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 4.34
Transcriptome profile of HepG2-expressing ATP7B-H1069Q (liver hepatocellular cells) exposed to JNK or p38 Inhibitor 4.33
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 4.32
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 4.29
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 4.28
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 4.27
Next Generation Sequencing upon siRNA-mediated knockdown of DRAIC in MCF-7 cells. 4.26
The cohesin complex prevents Myc-induced replication stress 4.25
scRNASeq analysis of cycling cardiomyocytes 4.23
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 4.22
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 4.21
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 4.21
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 4.21
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 4.12
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 4.11
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 4.04
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 3.98
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 3.93
An integrative analysis of non-coding regulatory DNA variations associated with autism 3.93
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 3.89
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 3.85
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 3.81
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 3.81
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 3.81
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 3.79
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 3.79
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 3.78
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 3.78
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 3.78
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 3.7
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 3.7
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 3.68
RNA sequencing of MDA-MB231 and U2OS cancer cell lines exposed to the alkylating agent methyl methanesufonate (MMS) and classical chemotherapeutics  3.68
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 3.67
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 3.66
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.62
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.62
Positively selected enhancer elements endow tumor cells with metastatic competence 3.57
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 3.55
Mapping interactions for the TNIP2 hub protein 3.55
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 3.47
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 3.47
Metastasis in triple-negative breast cancer 3.41
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 3.41
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.34
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 3.26
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 3.22
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 3.22
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 3.22
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 3.21
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 3.19
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 3.14
MARS Seq data from human cortical organoids 3.14
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 3.14
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 3.12
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 3.1
RNA sequencing of mechanically strained NHEKs and control NHEKs 3.07
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.07
mRNA sequencing of highly and lowly metastatic human colorectal cancer PDXs 3.05
Functional significance of the HIV-1 Tat signature amino acid residues 2.95
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.92
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 2.88
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 2.86
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 2.86
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 2.86
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 2.74
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 2.72
HEK293 TFAM Knockout Expression Study 2.65
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 2.63
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 2.61
Single-cell analysis of human kidney organoids 2.54
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 2.53
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 2.45
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 2.45
O-glcnAc reprograms cellular energetics 2.45
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 2.42
ADAR1-editing of cellular and measles virus-derived duplex RNA 2.39
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 2.39
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 2.33
RNA seq with AML (NB4) cells upon FTO inhibition 2.23
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 2.23
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 2.22
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 2.21
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 2.2
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 2.19
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 2.18
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 2.18
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 2.17
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 2.17
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 2.15
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 2.13
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 2.07
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 2.07
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 2.06
DAOY-Notch1/Notch2 knockout: transcriptome comparison 2.05
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 2.04
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.03
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [BAV] 2.01
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 2.0
Changes in human endometrial gland transcriptome over the window of implantation 1.94
Transcriptome analysis of CNS leukemia 1.94
RNA-seq analysis of primary patient samples to characterize the CNS leukemia 1.94
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.9
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 1.89
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 1.89
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 1.88
Induction of Cardiomyocyte Proliferation [pz-822_human] 1.88
Genes altered in expression by Cisplatin treatment in lung cancer cell lines 1.85
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 1.84
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.81
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 1.8
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 1.76
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 1.74
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.69
Genome-wide DNA hypomethylation and RNA:DNA hybrid accumulation in Aicardi-Goutières syndrome 1.66
The impact of oil spill to lung health – insights from an RNA-seq study of human airway epithelial cells 1.64
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 1.64
RNA-seq expression data from EB-HSPC after AM580 treatment compated to DMSO-trated and FL-HSPCs 1.63
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 1.6
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 1.59
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 1.59
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.59
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 1.57
Impact on erythroid progenitor type on erythroid differntiation 1.56
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 1.56
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 1.55
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 1.53
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 1.52
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 1.52
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 1.51
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 1.49
Wnt5a and its downstream transcription factor Stat3 are therapeutic targets for diffuse intrinsic pontine gliomas 1.47
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.47
A novel target of EZH1/2 for treatment of mantle cell lymphoma 1.44
An atlas of TNF-α-responsive promoters and enhancers in the intestinal epithelial cell model Caco-2 1.43
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 1.4
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 1.4
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 1.4
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 1.4
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.33
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 1.3
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 1.26
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.25
Regulation of poly(A) tail and translation during the somatic cell cycle 1.22
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 1.21
Wide-scale analysis of alternative polyadenylation (APA) associated with proliferation and transformation using 3'-Seq 1.17
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 1.16
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 1.15
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.15
Gene expression profile in breast cancer cells 1.15
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 1.13
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  1.09
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 1.09
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 1.08
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.07
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.06
Iron response of HepG2 cells 1.04
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 1.04
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 1.02
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 1.02
Function and hormonal regulation of GATA3 in human first trimester placentation 1.0
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 0.99
HBEC-shp53-PCHD7 0.97
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 0.93
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.9
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 0.88
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 0.88
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 0.83
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.78
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 0.78
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.76
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 0.73
Analysis of gene expression in SKOV3 ovarian cancer cells after knockdown of the long non-coding RNA DNM3OS 0.69
KSDM1b Role in Ewing Sarcoma 0.68
Regulation of highly expressed hCINAP on translatome 0.67
Profiling of escape kinetics of viruses subjected to RNAi 0.66
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.66
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.66
mRNA Sequencing of Human PromoCells Using 3'-directed Digital Gene Expression (3'-DGE) Technique 0.6
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.57
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 0.55
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 0.52
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 0.52
Tracing the first hematopoietic stem cell generation in human embryo by single-cell RNA sequencing 0.51
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.49
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 0.48
rG4-seq reveals widespread formation of G-quadruplex structures in the human transcriptome 0.41
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 0.41
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 0.41
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.4
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 0.39
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.37
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.34
Gene expression alterations of pancreatic intraepithlial neoplasia 0.31
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.27
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 0.27
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 0.19
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 0.19
RNA-seq data 0.16
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.15
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.15
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.1
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.1
Next generation sequencing of small RNAs isolated from exosomes in human semen 0.08
siRNA-mediated knockdown 0.06
Transcriptome-wide response to synthetic chromatin protein PcTF 0.03
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.02
Low-dose decitabine priming endows CAR T cells with enhanced and persistent anti-tumor potential by epigenetic reprogramming 0.01
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.01
miR-93 Targets in Human Endothelial Cells 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation